Dermatology · Fargo, ND
NPI
1639121304
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
4656 40th Ave S
Fargo, ND, 58104
Phone (701) 234-8860
Groups this clinician bills Medicare through
Medicare paid, 2024
$723K
8,120 services
Medicare patients, 2024
2,056
Average age 76
Drug cost, 2024
$29K
3,588 prescriptions
Company payments, 2024
$13.6
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas J Matzke was code 88305 (surgical pathology examination), 2,251 times for 1,275 patients. In total Thomas J Matzke billed 8,120 services in 117 codes, and Medicare paid $723K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 2,251 | 1,275 | $24.54 | $55K |
| 17311 Mohs Surgery | Office | 1,081 | 855 | $217.96 | $236K |
| 17312 Mohs Surgery | Office | 506 | 330 | $141.36 | $72K |
| 17003 Destruction Skin Lesion | Office | 478 | 122 | $1.72 | $820 |
| 99213 Office E&M - Established | Office | 409 | 335 | $48.92 | $20K |
| 88342 Immunohistochemistry | Office | 302 | 254 | $24.93 | $7,528 |
| 88341 Immunohistochemistry | Office | 274 | 184 | $20.34 | $5,572 |
| 17000 Destruction Skin Lesion | Office | 253 | 209 | $26.39 | $6,677 |
| 99212 Office E&M - Established | Office | 196 | 160 | $25.83 | $5,062 |
| 99214 Office E&M - Established | Office | 196 | 154 | $74.53 | $15K |
| 13132 Wound Repair - All Levels | Office | 190 | 186 | $124.59 | $24K |
| 12052 Wound Repair - All Levels | Office | 175 | 165 | $77.99 | $14K |
| 17262 Destruction Skin Lesion | Office | 117 | 97 | $63.79 | $7,464 |
| 12032 Wound Repair - All Levels | Office | 115 | 107 | $93.16 | $11K |
| 13121 Wound Repair - All Levels | Office | 108 | 97 | $123.74 | $13K |
By year: 2022 $554K for 8,520 services; 2023 $671K for 10,002 services; 2024 $723K for 8,120 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 2,251 | 1,275 | $24.54 | $55K |
| 88342 Immunohistochemistry | 302 | 254 | $24.93 | $7,528 |
| 88341 Immunohistochemistry | 274 | 184 | $20.34 | $5,572 |
| 88304 Surgical Pathology Examination | 30 | 28 | $8.22 | $247 |
| 88312 Surgical Pathology Examination | 28 | 20 | $20.02 | $560 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas J Matzke prescribed most often to Medicare patients was Mupirocin, with 1,464 prescriptions and refills. In total Thomas J Matzke wrote 3,588 Medicare prescriptions that cost $29K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mupirocin Generic | 1,464 | 1,477 | 1,297 | $10K |
| Cephalexin Generic | 1,450 | 1,452 | 1,251 | $5,296 |
| Doxycycline Hyclate Generic | 330 | 340 | 274 | $2,392 |
| Triamcinolone Acetonide Generic | 46 | 51 | 21 | $358 |
| Fluorouracil Generic | 45 | 50 | 37 | $3,109 |
| Ketoconazole Generic | 40 | 41 | 31 | $862 |
| Hydrocortisone Generic | 17 | 17 | 13 | $91.66 |
| Clobetasol Propionate Generic | 15 | 15 | 12 | $673 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 14 | 14 | 14 | $41.28 |
| Clindamycin Phosphate Generic | 14 | 16 | Under 11 | $489 |
| Fluocinonide Generic | 12 | 13 | Under 11 | $681 |
| Prednisone Generic | 12 | 14 | Under 11 | $87.57 |
| Tacrolimus Generic | 11 | 11 | Under 11 | $954 |
Brand drugs: 17 claims; generic drugs: 3,571 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Thomas J Matzke $13.6 ($13.6 in general payments such as food, travel and fees) from 1 company. The largest payer was Kerecis Limited with $13.6.
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 1 | $13.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.